SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-071093
Filing Date
2023-12-18
Accepted
2023-12-18 16:16:25
Documents
13
Period of Report
2023-12-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20231214.htm   iXBRL 8-K 47843
2 EX-3.1 lyra-ex3_1.htm EX-3.1 305172
  Complete submission text file 0000950170-23-071093.txt   517520

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyra-20231214.xsd EX-101.SCH 2481
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyra-20231214_pre.xml EX-101.PRE 10235
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyra-20231214_lab.xml EX-101.LAB 13887
7 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20231214_htm.xml XML 4879
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 231493931
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)